Jeffrey T. L. Smith, Managing Director at ALDER BIOPHARMACEUTICALS INC (ALDR), sold 24,322 shares at $15.49 ($377K) on 2018-07-02, disclosed to the SEC on 2018-07-03.
Open-market sale of $377k ALDR by Managing Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.49 | 12,161 | $188K | 50.0% |
| 2 | $15.49 | 12,161 | $188K | 50.0% |
| Total | $15.49 avg | 24,322 | $377K | 100% |
| Filing → |
| ZYME | SELL | 2025-01-06 | $332K | — | Filing → |
| ALDR | SELL | 2019-09-18 | $1.2M | — | Filing → |
| ALDR | SELL | 2018-12-04 | $140K | — | Filing → |